One couple we helped had ticked every box their specialist set. Tests done, timing right, a plan they understood and trusted. The thing that almost ended it had nothing to do with their biology. It was the drive. Their closest clinic was about ninety minutes away, and one round of IVF meant doing that drive over and over for monitoring, usually at dawn and often booked in at a day’s notice. Two weeks in, they were asking each other whether it was worth carrying on.
You don’t hear those stories in most conversations about access to IVF. Those tend to stay on cost and eligibility, which matter, but they miss something. Where a clinic actually sits quietly decides who makes it through treatment and who gives up along the way.
Access to IVF is a logistics problem as much as a medical one
Picture what a cycle really demands. It isn’t one visit. Across a week or two of stimulation, a patient comes in again and again for blood tests and ultrasounds, so the team can watch how the ovaries respond and tune the medication accordingly. And the clock matters. Egg collection sits inside a tight window, and the monitoring that sets it up has to follow the body rather than the appointment book.
Live ten minutes away and all of this is a nuisance you absorb. Live two hours away and it becomes a small expedition, repeated through the fortnight, wedged between shifts and school runs and everything else. Same medicine, either way. Reaching it is the part that differs. So access is partly geography, and geography is one of the few things a provider can actually plan around.
What distance actually costs patients and clinics
Distance bills both sides. For patients it turns into leave from work, petrol and parking, the odd night in a motel, and now and then a quiet decision to put a cycle off until things settle down. When a patient is older, putting it off is not a neutral choice. A few walk away entirely. The treatment didn’t let them down; the trip around it did.
The clinic feels the same distance from the other direction: appointments missed or shuffled, holes in the monitoring that throw a cycle off, and catchments that fill lopsidedly, one city site overloaded while people further out get too little. A patient who can get to monitoring without a production is far likelier to finish the cycle as planned, and finished cycles are easier on the roster, cleaner in the outcome data, and better for the clinic’s name. So proximity isn’t only the humane option. It pays its way.
Location strategy as an operational lever
Which is why location belongs in the clinical and operational conversation, not just the property one. A couple of models have grown up to close the gap between patient and care.
The familiar one is hub and satellite. The lab and the procedures that truly need specialist kit live at a central site, while smaller clinics nearer to where people live take on the high-frequency, low-complexity work: the scans and blood tests that make up the bulk of a cycle’s visits. A patient can do most of their monitoring close to home and only travel to the hub for collection and transfer.
Telehealth has pushed the idea along. First consultations, going over results, a lot of the support that wraps around treatment: none of it strictly needs a waiting room any more. Put a physical footprint together with remote care and you save the in-person trips for the things that genuinely demand a body in the building. Handled well, it widens access to IVF without watering down the care, because the clinical core stays put while the routine edges drift closer to the patient.
Regional snapshot: how networks widen access
A real example makes this easier to picture, and Australia is a handy one. Medicare rebates and bulk-billing take some of the sting out of the price here, so cost blocks fewer people than it does in, say, the United States, which leaves the geographic hurdle standing out all the more. Australians also pile into a few coastal cities, so one clinic in the middle of a central business district can look reachable on a map and still be a real trek for a family out in the suburbs.
Our own setup leans on this. Rather than stacking everything into one city-centre address, we run two Sydney clinics: one in Surry Hills near the inner city, the other in Parramatta for the west, both a short walk from a train station. That spread is deliberate. It means families looking for IVF in Sydney can usually reach monitoring from either side of the city without rebuilding their week around the trip. Two addresses isn’t a grand network. It just follows where patients already are, instead of asking them to come to us.
Designing for access, not just capacity
When the waiting list grows, the easy reflex is to pack more into the rooms you’ve got. More chairs, longer days, a larger central clinic. That buys throughput but does nothing for reach, and it can widen the gap for the very people who were already struggling to get there.
The harder, better move is to treat access to IVF as something you measure, right next to success rates and waiting times. How far is the typical patient driving for monitoring? How many cycles stall or collapse for reasons that have nothing to do with whether the treatment suits them? Siting clinics by travel time and catchment, backing them with telehealth, and being plain about where you are and what it costs aren’t PR gestures. They shape who actually finishes a cycle. In a field that exists to help people build families, that is worth getting right on purpose.